ConductScience.org, home

Trial · NCT00966264

Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia

NCT00966264, Phase 3, Completed, University of Helsinki; results first posted 2009-08-26

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia. Trials, record NCT00966264. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00966264

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia
NCT number
NCT00966264
Status
Completed
Phases
Phase 3
Enrollment
236 participants, actual
Lead sponsor
University of Helsinki
Conditions
Menorrhagia
Interventions
LNG-IUS, Hysterectomy
First posted
2009-08-26
Last updated
2009-09-02
Results first posted
2009-08-26

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryHRQoL (Health Related Quality of Life)baseline and 5 years
HRQoL was measured by the 5-Dimensional EuroQol (EQ-5D) questionnaire which measures HRQoL in 5 dimensions of life (scale 0-1)(from very poor=0 to very good=5). The results are the change of HRQoL from baseline at 5 years (EQ-5D score at 5 years - EQ-5D score at baseline)
PrimaryCostsbaseline, 6 and 12 months, 5 and 10 years
SecondaryDepressionbaseline, 6 and 12 months, 5 and 10 years

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYHRQoL (Health Related Quality of Life)baseline and 5 yearsThe power calculation was made on the basis of an EQ-5D score SD of 19% and alfa=0.05. The study had 80% power to detect a 7.5% difference between the groupspoints on a scaleMEAN
PRIMARYCostsbaseline, 6 and 12 months, 5 and 10 yearsNUMBER
SECONDARYDepressionbaseline, 6 and 12 months, 5 and 10 years

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
HRQoL (Health Related Quality of Life)LNG-IUS0.0895% Confidence Interval 0.03 to 0.13points on a scale
HRQoL (Health Related Quality of Life)Hysterectomy0.1095% Confidence Interval 0.05 to 0.15points on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDLNG-IUS119
Overall StudySTARTEDHysterectomy117
Overall StudyCOMPLETEDLNG-IUS115
Overall StudyCOMPLETEDHysterectomy114
Overall StudyNOT COMPLETEDLNG-IUS4
Overall StudyNOT COMPLETEDHysterectomy3

Adverse events18

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherhormonal symptomsSurgical and medical proceduresLNG-IUS1811918
otherhormonal symptomsSurgical and medical proceduresHysterectomy01170
othermenstrual bleeding problemsSurgical and medical proceduresLNG-IUS6111961
othermenstrual bleeding problemsSurgical and medical proceduresHysterectomy21172
otherwund infectionSurgical and medical proceduresLNG-IUS9509
otherwund infectionSurgical and medical proceduresHysterectomy2010920
otherperioperative bleedingSurgical and medical proceduresLNG-IUS1501
otherperioperative bleedingSurgical and medical proceduresHysterectomy11091
otherpostoperative bleedingSurgical and medical proceduresLNG-IUS1501
otherpostoperative bleedingSurgical and medical proceduresHysterectomy21092

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityLNG-IUS
Total, all-cause mortalityHysterectomy
Total, other adverse eventsLNG-IUS80
Total, other adverse eventsHysterectomy25
Total, serious adverse eventsLNG-IUS0
Total, serious adverse eventsHysterectomy5

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00966264

GET https://conductscience.org/api/trials/v1/NCT00966264/registered